Purchase Order HHSN268201700116A

This is a $1,074,709 firm fixed-price definitive contract awarded to the Translational Genomics Research Institute (TGen), a non-profit research organization, by the Centers for Disease Control and Prevention (CDC) for the FY 21 BAA TOPIC 8 - TGRI project. The contract has a period of performance through May 14, 2023 and was awarded on May 15, 2021 with no set-aside designation. TGen is a leading institute in precision medicine and translational bioscience, specializing in genomic analyses,...

This federal contract award, valued at $1,472,866.08, was issued by the Centers for Disease Control and Prevention (CDC) to the Translational Genomics Research Institute (TGen), a non-profit biomedical research organization. The contract provides bioinformatics support services, including genomic sequencing, analysis, and data services, to advance precision medicine research. TGen has previously conducted genomic research and analysis work for several federal agencies, such as the National...

This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract, valued at $109,504.00, is a Definitive Contract with a Firm Fixed Price under Broad Agency Announcement (BAA) 2017. The contract does not have a set-aside designation. Under this contract, TGen will provide a variety of genomic research services, including SARS-CoV-2...

The National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. government, has awarded a $46,984.32 firm-fixed-price purchase order contract to The Regents of the University of California, San Francisco (UCSF) for AFFE GENE TITAN AXIOM, 8 WHOLE GENOME DNA GENOTYPING FOR 864 SAMPLES. This contract, which does not have a set-aside designation, originates from a solicitation for whole genome DNA genotyping services related to Systemic Lupus Erythematosus (SLE) research....

This is a $145,000.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract is for RUN DATA SAMPLES services, with a completion date of September 29, 2024. TGen has previously performed genomic research services for federal agencies under both contracts and grants, including work related to SARS-CoV-2,...

This purchase order, awarded by the National Institutes of Health's National Institute of Child Health and Human Development, is for one unit of HAPLOGEN HAP1DEPDC52039600 CRISPR/CAS9-EDITED DEPDC5 for $1,105.90, with a total contract value of $5,728.50. The prime contractor, Government Scientific Source Inc. doing business as G S S, will deliver the product from its place of performance in Herndon, Virginia between September 11, 2014 and October 31, 2014 under firm fixed pricing. No set aside...

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $23,018 firm fixed price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE. The contract period is December 25, 2023 through December 24, 2024. Qiagen will provide access to and use of the Human Gene Mutation Database for research purposes under this contract. The place of performance is Qiagen's Biltmore Forest, North Carolina facility. The National Human...

This is a delivery order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to The Emmes Company LLC, a global clinical research organization. The $436,388 contract provides protocol monitoring and data management support services for NHGRI's research protocols under Task Area 1. This delivery order is issued under a larger $4 million indefinite delivery/indefinite quantity (IDIQ) contract vehicle called...

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...

This federal contract award, valued at $20,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Genedx, LLC, a wholly owned subsidiary of Opko Health, Inc. The contract provides for the Genedx Hereditary MDS/Leukemia Panel (T830) and Copy Number Variation (CNV) testing services to be made available to potential participants who do not otherwise have access to this genetic testing. The contract is structured as a firm fixed-price purchase order with a period of...